Global Gestational Diabetes Treatment Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Gestational Diabetes Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Insulin
  • 1.2.3 SGLT-2 Inhibitors
  • 1.2.4 Alpha-glucosidase Inhibitors
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Gestational Diabetes Treatment Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Gestational Diabetes Treatment Market Perspective (2016-2027)
• 2.2 Gestational Diabetes Treatment Growth Trends by Regions
  • 2.2.1 Gestational Diabetes Treatment Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Gestational Diabetes Treatment Historic Market Share by Regions (2016-2021)
  • 2.2.3 Gestational Diabetes Treatment Forecasted Market Size by Regions (2022-2027)
• 2.3 Gestational Diabetes Treatment Industry Dynamic
  • 2.3.1 Gestational Diabetes Treatment Market Trends
  • 2.3.2 Gestational Diabetes Treatment Market Drivers
  • 2.3.3 Gestational Diabetes Treatment Market Challenges
  • 2.3.4 Gestational Diabetes Treatment Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Gestational Diabetes Treatment Players by Revenue
  • 3.1.1 Global Top Gestational Diabetes Treatment Players by Revenue (2016-2021)
  • 3.1.2 Global Gestational Diabetes Treatment Revenue Market Share by Players (2016-2021)
• 3.2 Global Gestational Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Gestational Diabetes Treatment Revenue
• 3.4 Global Gestational Diabetes Treatment Market Concentration Ratio
  • 3.4.1 Global Gestational Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Gestational Diabetes Treatment Revenue in 2020
• 3.5 Gestational Diabetes Treatment Key Players Head office and Area Served
• 3.6 Key Players Gestational Diabetes Treatment Product Solution and Service
• 3.7 Date of Enter into Gestational Diabetes Treatment Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Gestational Diabetes Treatment Breakdown Data by Type

• 4.1 Global Gestational Diabetes Treatment Historic Market Size by Type (2016-2021)
• 4.2 Global Gestational Diabetes Treatment Forecasted Market Size by Type (2022-2027)

5 Gestational Diabetes Treatment Breakdown Data by Application

• 5.1 Global Gestational Diabetes Treatment Historic Market Size by Application (2016-2021)
• 5.2 Global Gestational Diabetes Treatment Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Gestational Diabetes Treatment Market Size (2016-2027)
• 6.2 North America Gestational Diabetes Treatment Market Size by Type
  • 6.2.1 North America Gestational Diabetes Treatment Market Size by Type (2016-2021)
  • 6.2.2 North America Gestational Diabetes Treatment Market Size by Type (2022-2027)
  • 6.2.3 North America Gestational Diabetes Treatment Market Size by Type (2016-2027)
• 6.3 North America Gestational Diabetes Treatment Market Size by Application
  • 6.3.1 North America Gestational Diabetes Treatment Market Size by Application (2016-2021)
  • 6.3.2 North America Gestational Diabetes Treatment Market Size by Application (2022-2027)
  • 6.3.3 North America Gestational Diabetes Treatment Market Size by Application (2016-2027)
• 6.4 North America Gestational Diabetes Treatment Market Size by Country
  • 6.4.1 North America Gestational Diabetes Treatment Market Size by Country (2016-2021)
  • 6.4.2 North America Gestational Diabetes Treatment Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Gestational Diabetes Treatment Market Size (2016-2027)
• 7.2 Europe Gestational Diabetes Treatment Market Size by Type
  • 7.2.1 Europe Gestational Diabetes Treatment Market Size by Type (2016-2021)
  • 7.2.2 Europe Gestational Diabetes Treatment Market Size by Type (2022-2027)
  • 7.2.3 Europe Gestational Diabetes Treatment Market Size by Type (2016-2027)
• 7.3 Europe Gestational Diabetes Treatment Market Size by Application
  • 7.3.1 Europe Gestational Diabetes Treatment Market Size by Application (2016-2021)
  • 7.3.2 Europe Gestational Diabetes Treatment Market Size by Application (2022-2027)
  • 7.3.3 Europe Gestational Diabetes Treatment Market Size by Application (2016-2027)
• 7.4 Europe Gestational Diabetes Treatment Market Size by Country
  • 7.4.1 Europe Gestational Diabetes Treatment Market Size by Country (2016-2021)
  • 7.4.2 Europe Gestational Diabetes Treatment Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Gestational Diabetes Treatment Market Size (2016-2027)
• 8.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type
  • 8.2.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application
  • 8.3.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Gestational Diabetes Treatment Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Gestational Diabetes Treatment Market Size by Region
  • 8.4.1 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Gestational Diabetes Treatment Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Gestational Diabetes Treatment Market Size (2016-2027)
• 9.2 Latin America Gestational Diabetes Treatment Market Size by Type
  • 9.2.1 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2021)
  • 9.2.2 Latin America Gestational Diabetes Treatment Market Size by Type (2022-2027)
  • 9.2.3 Latin America Gestational Diabetes Treatment Market Size by Type (2016-2027)
• 9.3 Latin America Gestational Diabetes Treatment Market Size by Application
  • 9.3.1 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2021)
  • 9.3.2 Latin America Gestational Diabetes Treatment Market Size by Application (2022-2027)
  • 9.3.3 Latin America Gestational Diabetes Treatment Market Size by Application (2016-2027)
• 9.4 Latin America Gestational Diabetes Treatment Market Size by Country
  • 9.4.1 Latin America Gestational Diabetes Treatment Market Size by Country (2016-2021)
  • 9.4.2 Latin America Gestational Diabetes Treatment Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Gestational Diabetes Treatment Market Size (2016-2027)
• 10.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type
  • 10.2.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application
  • 10.3.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Gestational Diabetes Treatment Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Gestational Diabetes Treatment Market Size by Country
  • 10.4.1 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Gestational Diabetes Treatment Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Biocon Limited
  • 11.1.1 Biocon Limited Company Details
  • 11.1.2 Biocon Limited Business Overview
  • 11.1.3 Biocon Limited Gestational Diabetes Treatment Introduction
  • 11.1.4 Biocon Limited Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.1.5 Biocon Limited Recent Development
• 11.2 Eli Lilly
  • 11.2.1 Eli Lilly Company Details
  • 11.2.2 Eli Lilly Business Overview
  • 11.2.3 Eli Lilly Gestational Diabetes Treatment Introduction
  • 11.2.4 Eli Lilly Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.2.5 Eli Lilly Recent Development
• 11.3 Novo Nordisk
  • 11.3.1 Novo Nordisk Company Details
  • 11.3.2 Novo Nordisk Business Overview
  • 11.3.3 Novo Nordisk Gestational Diabetes Treatment Introduction
  • 11.3.4 Novo Nordisk Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.3.5 Novo Nordisk Recent Development
• 11.4 Boehringer Ingelheim GmbH
  • 11.4.1 Boehringer Ingelheim GmbH Company Details
  • 11.4.2 Boehringer Ingelheim GmbH Business Overview
  • 11.4.3 Boehringer Ingelheim GmbH Gestational Diabetes Treatment Introduction
  • 11.4.4 Boehringer Ingelheim GmbH Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.4.5 Boehringer Ingelheim GmbH Recent Development
• 11.5 Sanofi S.A.
  • 11.5.1 Sanofi S.A. Company Details
  • 11.5.2 Sanofi S.A. Business Overview
  • 11.5.3 Sanofi S.A. Gestational Diabetes Treatment Introduction
  • 11.5.4 Sanofi S.A. Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.5.5 Sanofi S.A. Recent Development
• 11.6 Sun Pharmaceutical Industries Limited
  • 11.6.1 Sun Pharmaceutical Industries Limited Company Details
  • 11.6.2 Sun Pharmaceutical Industries Limited Business Overview
  • 11.6.3 Sun Pharmaceutical Industries Limited Gestational Diabetes Treatment Introduction
  • 11.6.4 Sun Pharmaceutical Industries Limited Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.6.5 Sun Pharmaceutical Industries Limited Recent Development
• 11.7 Merck
  • 11.7.1 Merck Company Details
  • 11.7.2 Merck Business Overview
  • 11.7.3 Merck Gestational Diabetes Treatment Introduction
  • 11.7.4 Merck Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.7.5 Merck Recent Development
• 11.8 Novartis
  • 11.8.1 Novartis Company Details
  • 11.8.2 Novartis Business Overview
  • 11.8.3 Novartis Gestational Diabetes Treatment Introduction
  • 11.8.4 Novartis Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.8.5 Novartis Recent Development
• 11.9 Adocia
  • 11.9.1 Adocia Company Details
  • 11.9.2 Adocia Business Overview
  • 11.9.3 Adocia Gestational Diabetes Treatment Introduction
  • 11.9.4 Adocia Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.9.5 Adocia Recent Development
• 11.10 Peptron
  • 11.10.1 Peptron Company Details
  • 11.10.2 Peptron Business Overview
  • 11.10.3 Peptron Gestational Diabetes Treatment Introduction
  • 11.10.4 Peptron Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.10.5 Peptron Recent Development
• 11.11 AstraZeneca plc
  • 11.11.1 AstraZeneca plc Company Details
  • 11.11.2 AstraZeneca plc Business Overview
  • 11.11.3 AstraZeneca plc Gestational Diabetes Treatment Introduction
  • 11.11.4 AstraZeneca plc Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.11.5 AstraZeneca plc Recent Development
• 11.12 Pfizer, Inc
  • 11.12.1 Pfizer, Inc Company Details
  • 11.12.2 Pfizer, Inc Business Overview
  • 11.12.3 Pfizer, Inc Gestational Diabetes Treatment Introduction
  • 11.12.4 Pfizer, Inc Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.12.5 Pfizer, Inc Recent Development
• 11.13 Takeda Pharmaceutical Company Ltd
  • 11.13.1 Takeda Pharmaceutical Company Ltd Company Details
  • 11.13.2 Takeda Pharmaceutical Company Ltd Business Overview
  • 11.13.3 Takeda Pharmaceutical Company Ltd Gestational Diabetes Treatment Introduction
  • 11.13.4 Takeda Pharmaceutical Company Ltd Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.13.5 Takeda Pharmaceutical Company Ltd Recent Development
• 11.14 Abbott
  • 11.14.1 Abbott Company Details
  • 11.14.2 Abbott Business Overview
  • 11.14.3 Abbott Gestational Diabetes Treatment Introduction
  • 11.14.4 Abbott Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.14.5 Abbott Recent Development
• 11.15 Antares Pharma
  • 11.15.1 Antares Pharma Company Details
  • 11.15.2 Antares Pharma Business Overview
  • 11.15.3 Antares Pharma Gestational Diabetes Treatment Introduction
  • 11.15.4 Antares Pharma Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.15.5 Antares Pharma Recent Development
• 11.16 INJEX Pharma AG
  • 11.16.1 INJEX Pharma AG Company Details
  • 11.16.2 INJEX Pharma AG Business Overview
  • 11.16.3 INJEX Pharma AG Gestational Diabetes Treatment Introduction
  • 11.16.4 INJEX Pharma AG Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.16.5 INJEX Pharma AG Recent Development
• 11.17 Daiichi Sankyo
  • 11.17.1 Daiichi Sankyo Company Details
  • 11.17.2 Daiichi Sankyo Business Overview
  • 11.17.3 Daiichi Sankyo Gestational Diabetes Treatment Introduction
  • 11.17.4 Daiichi Sankyo Revenue in Gestational Diabetes Treatment Business (2016-2021)
  • 11.17.5 Daiichi Sankyo Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer